The global stem cells market is slated to hit $270.5 billion by 2025, according to a Transparency Market Research report.
Here are five highlights:
1. The market will grow at a compound annual growth rate of 13.8 percent through 2025.
2. The adult stem cell sector captures the greatest market share, due to the cells ability to recreate trillions of specialized cells.
3. Currently, North America leads the market, because of investments, advanced technology and a rise in chronic disease cases. The region will likely hit $167.3 billion by 2025.
4. A key trend in the market is for stem cell companies to partner with pharmaceutical companies to increase revenue.
5. Key market players include STEMCELL Technologies, Astellas Pharma, Cellular Engineering Technologies, BioTime, Takara Bio, U.S. Stem Cell, BrainStorm Cell Therapeutics, Cytori Therapeutics, Osiris Therapeutics and Caladrius Biosciences.